As such, iron removal therapy has become a potential treatment strategy for NASH.6,7 Given its role in regulating iron homeostasis, Hamp has gained attention as a promising therapeutic agent that can remove liver iron stores.13,14 In the present study, our data showed that rAAV2/8-Hamp treatment significantly suppressed CDAA diet-induced steatosis, hepatic inflammation, and subsequent liver fibrosis in mice.